Personalized PATH plan for healthier use and recovery

Understanding and Treating Substance Use Disorder and Comorbid Conditions in Veterans' Real-Life Settings

Not applicable Interventional VA Office of Research and Development · NCT06580457

This project will try giving Veterans with substance use disorder a personal model of what causes their urges and substance use plus a one-hour feedback session to see if that helps their symptoms and recovery.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment74 (estimated)
Ages18 Years and up
SexAll
SponsorVA Office of Research and Development Federal
Locations1 site (Minneapolis, Minnesota)
Trial IDNCT06580457 on ClinicalTrials.gov

What this trial studies

The trial enrolls 74 Veterans with probable substance use disorder who complete a personalized 4-week ecological momentary assessment (EMA) protocol measuring substance use, urges, and comorbid symptoms multiple times per day. Investigators will generate an individualized causal model from each participant's EMA data using causal discovery methods. Participants are randomized to receive their personal causal model plus an hour of clinical feedback and follow-up reminders or to a control condition. Outcomes include changes in substance use and comorbid symptoms, statistically derived and self-reported causes, and participant feedback on the intervention's relevance.

Who should consider this trial

Good fit: Ideal candidates are Veterans with a current probable substance use disorder who have used substances in the past month and can reliably complete smartphone- or tablet-based surveys throughout the day.

Not a fit: Patients who are legally compelled to participate, under civil commitment, currently in inpatient treatment, intoxicated at consent, or without reliable access to a smartphone or tablet are unlikely to be eligible or to benefit.

Why it matters

Potential benefit: If successful, participants may gain clearer, personalized insight into triggers and receive targeted feedback that helps reduce substance use and related symptoms.

How similar studies have performed: Preliminary work using EMA and personalized causal models has shown promise for identifying individual triggers, but delivering those models as clinical feedback to improve outcomes remains relatively novel and not yet widely proven.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Inclusion criteria for this study are intended to include most Veterans with SUD
* inclusion criteria are current probable SUD as indicated by:

  * a clinical score on the alcohol use disorders identification test (AUDIT) or drug use disorders identification test (DUDIT)
  * past-month substance use
  * a reliable access to a smartphone, tablet, or other device with capability of accessing and completing surveys throughout the day

    * this will exclude those who are currently completing inpatient treatment

Exclusion Criteria:

* exclusion criteria are being under the influence of a judgment-impairing substance at the time of consent (e.g., cannabis, alcohol, illicit opioids)

  * participants will be invited to return another day
* being legally compelled to complete treatment
* or being under civil commitment

  * due to lack of ability to give autonomous consent in these situations

Where this trial is running

Minneapolis, Minnesota

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Substance Use Disordersubstance use disorderprecision medicineecological momentary assessment
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.